These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 7668025)
1. Enhanced superoxide anion release of normal neutrophil granulocytes primed with sera of patients with inactive inflammatory bowel disease. Griga T; Tromm A; Schwegler U; May B Z Gastroenterol; 1995 Jul; 33(6):345-8. PubMed ID: 7668025 [TBL] [Abstract][Full Text] [Related]
2. Superoxide anion production and phospholipase D-mediated generation of diacylglycerol are subnormal after N-formyl-methionyl-leucyl-phenylalanine stimulation of polymorphonuclear granulocytes in polycythemia vera. Samuelsson J; Hansson A; Rosendahl K; Palmblad J J Lab Clin Med; 1993 Feb; 121(2):310-9. PubMed ID: 8381848 [TBL] [Abstract][Full Text] [Related]
3. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718 [TBL] [Abstract][Full Text] [Related]
4. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis. Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925 [TBL] [Abstract][Full Text] [Related]
5. [The metabolic and phagocytic activities of the neutrophilic granulocytes in patients with nonspecific ulcerative colitis nd Crohn's disease]. Blazhenko IL; Bychkova NG; Shvets NI Vrach Delo; 1990 Jun; (6):61-2. PubMed ID: 2399726 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease. Griga T; Hebler U; Voigt E; Tromm A; May B Hepatogastroenterology; 2000; 47(36):1604-7. PubMed ID: 11149012 [TBL] [Abstract][Full Text] [Related]
7. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Griga T; Voigt E; Gretzer B; Brasch F; May B Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639 [TBL] [Abstract][Full Text] [Related]
8. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452 [TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease. Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192 [TBL] [Abstract][Full Text] [Related]
11. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Keshavarzian A; Fusunyan RD; Jacyno M; Winship D; MacDermott RP; Sanderson IR Am J Gastroenterol; 1999 Mar; 94(3):704-12. PubMed ID: 10086655 [TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-, granulocyte-monocyte colony stimulating factor and pentoxifylline-mediated effects on formyl-methionyl-leucine-phenylalanine-stimulated neutrophil respiratory burst in the elderly. Tortorella C; Polignano A; Piazzolla G; Serrone M; Jirillo E; Antonaci S Microbios; 1996; 85(344):189-98. PubMed ID: 8676749 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Griga T; May B; Pfisterer O; Müller KM; Brasch F Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933 [TBL] [Abstract][Full Text] [Related]
15. Demonstration and characterization of immunosuppressive factors in sera from patients with Crohn's disease. Watanabe M; Tsuru S; Zinnaka Y; Yoshida T; Aiso S; Hibi T; Asakura H; Tsuchiya M J Clin Lab Immunol; 1985 May; 17(1):13-9. PubMed ID: 4045994 [TBL] [Abstract][Full Text] [Related]
16. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B; Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104 [TBL] [Abstract][Full Text] [Related]
17. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637 [TBL] [Abstract][Full Text] [Related]